<DOC>
	<DOCNO>NCT02293382</DOCNO>
	<brief_summary>The objective perform retrospective chart review generate data evaluate clinical characteristic course disease progression MPS IIIB .</brief_summary>
	<brief_title>A Retrospective Chart Review Deceased Patients With Mucopolysaccharidosis Type IIIB</brief_title>
	<detailed_description />
	<mesh_term>Mucopolysaccharidoses</mesh_term>
	<mesh_term>Mucopolysaccharidosis III</mesh_term>
	<criteria>1 . The deceased patient diagnose MPS IIIB determine either follow : 1 . Documented deficiency NAGLU enzyme activity . 2 . Documented functionallyrelevant mutation allele NAGLU gene . 2 . Patient 's parent legal guardian provide informed consent ( unless requirement inform consent waive local regulation ) . 3 . The availability predefined information patient 's clinical chart : There exclusion criterion study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>MPS IIIB</keyword>
	<keyword>Mucopolysaccharodosis III</keyword>
	<keyword>Mucopolysaccharidosis type IIIB</keyword>
	<keyword>Sanfilippo Syndrome</keyword>
</DOC>